Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(98)
•••
RockLobster1
X
View Profile
View Bullboard History
Comment by
RockLobster1
on Aug 22, 2024 10:50am
RE:Tax deduction
Hi - in Canada you have to dispose of it.. ie sell or gift to your broker. It's the day you do that. Or use section 51(1) if I have that right where you claim the loss. That resets
...more
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Post by
Breakthorough1
on Mar 28, 2024 11:02am
Tax deduction
Hi, Does anyone knows if there is already a date to count the loss for tax deduction?
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Post by
Breakthorough1
on Mar 02, 2024 5:17pm
It will probably end curing cancers
Kenneth Kovan, BioVaxys President & Chief Operating Officer stated: “This is an absolutely transformational transaction for Biovaxys that is synergistic with our pre-existing personalized
...more
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Post by
Breakthorough1
on Mar 02, 2024 4:43pm
DPX is not dead. IMV is.
https://es-us.finanzas.yahoo.com/news/biovaxys-completes-acquisition-intellectual-property-185400843.html
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Post by
Breakthorough1
on Nov 01, 2023 2:34pm
Congrats to A. Hall, new CEO of Consano Biologics...
Experience Chief Executive Officer Consano Biologics Aug 2023 - Present4 months New York
...more
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Comment by
Breakthorough1
on Oct 25, 2023 1:13pm
RE:RE:VITALIZE Trial
Agree. But even like that. From the point of view of management reputation. Is is not easier to show them and so state clearly that the reason for becoming insolvent is not their incompetence, but an
...more
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Comment by
prosciutto
on Oct 25, 2023 1:08pm
RE:VITALIZE Trial
The only explanation that really makes sense is that the results must have been lack-lustre and they were aware of it.
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Post by
Breakthorough1
on Oct 16, 2023 12:31pm
VITALIZE Trial
In the last version submitted to the USA NCI page (September 11), you can see that there were 20 patients in arm 1 (with cph) and 14 in arm 2 (without cph) already enrolled. So 34 patients. The Stage
...more
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Post by
Breakthorough1
on Oct 01, 2023 3:33pm
Aug 11 2021, A. Hall
"So I will say at the top level, we remain committed to the time line we've set forward in the milestones we expect in the first half of next year to have the signal seeking part of the
...more
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Comment by
Breakthorough1
on Sep 29, 2023 4:25pm
RE:RE:RE:RE:This sounds serious if demonstrable
Yes, you can. Reach the Affidavit of Brittany Davison sworn on September 22 at the FTI page. The court has to take a decision about it -it will probably release the D&O.
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Sep 29, 2023 2:38pm
RE:RE:RE:This sounds serious if demonstrable
Curious as to where I may find the details online, noted below. Does it state who is handling the claim?
(1)
•••
anonamus
X
View Profile
View Bullboard History
Comment by
anonamus
on Sep 26, 2023 4:50am
RE:RE:Legal action (?)
I personally was invested in the Canadian ticker for this so the CSA would be the relevant body here (though unlike the SEC, I've quite literally never heard of the CSA doing anything before)
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Comment by
Breakthorough1
on Sep 25, 2023 4:15am
RE:Legal action (?)
But you can at least inform the SEC through the link I posted...
(1)
•••
anonamus
X
View Profile
View Bullboard History
Post by
anonamus
on Sep 24, 2023 7:20pm
Legal action (?)
I don't think anything is going to be done since none of us are willing to shell out the time/money needed for a lawyer or pursuing legal action. There doesn't seem to be a class-action suit
...more
(43)
•••
Breakthorough1
X
View Profile
View Bullboard History
Comment by
Breakthorough1
on Sep 24, 2023 2:10pm
RE:RE:RE:This sounds serious if demonstrable
I guess you should do it too. Much better if more people do. The link: https://www.sec.gov/tcr
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare to Report Q3 2024 Financial Results on November 14, 2024
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Nanalysis Announces Third Quarter 2024 Conference Call